Company Profiles: Revenue, Growth, Competition

ADAMAS PHARMACEUTICALS Revenue, Growth & Competitor Profile

Last updated:

Company Awards

Public Company
public company
Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP

Company Profile & Annual Report for Adamas Pharmaceuticals

Access the complete profile.

Adamas Pharmaceuticals Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
Employees100 - 500Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes32541
325412 Pharmaceutical Preparation Manufacturing
3255 Paint, Coating & Adhesive Manufacturing
Address1900 Powell Street
Suite 1000
Emeryville, CA 94608

Adamas Pharmaceuticals's annual revenues are $100-$500 million (see exact revenue data) and has 100-500 employees. It is classified as operating in the Medicinal & Botanical Manufacturing industry.

Adamas Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Adamas Pharmaceuticals is a publicly traded company on NGM using the ticker symbol ADMS. Detailed information on company financials and operating reports can be found here: NGM: ADMS

Adamas Pharmaceuticals Annual Revenue and Growth Rate

Adamas Pharmaceuticals Revenue Est.
($ Million)
Growth Rate (%)# Employees
2019 Details in Premium Report

1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Adamas Pharmaceuticals's revenues are gauged from an analysis of company filings.

Trademark Applications

Trademark applications show the products and services that Adamas Pharmaceuticals is developing and marketing. Adamas Pharmaceuticals doesn't have any recent trademark applications, indicating Adamas Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
Pharmaceuticals for the treatment of nervous system disorders
Pharmaceuticals for the treatment of nervous system disorders
Pharmaceuticals for the treatment of nervous system disorders

See all trademarks and details in the Full Report.

Recession Risk

Determine whether Adamas Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Adamas Pharmaceuticals is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.

U.S. Industry Overview & Market Statistics:
Medicinal & Botanical Manufacturing

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks

Market Share of Adamas Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Adamas Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
PANACEA BIOMATXResearch Triangle Park, NC100 

Nearby Competitors

These companies are similar in business line and location to Adamas Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
AMYRISEmeryville, CA100 
XOMAEmeryville, CA8 

Future Competition: Adamas Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Adamas Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Adamas Pharmaceuticals Competitors